Literature DB >> 31579518

Genetic counseling and tumor predisposition in neuro-oncology practice.

Erin M Dunbar1, Amanda Eppolito1, John W Henson1.   

Abstract

Tumor predisposition syndromes may be under-recognized in neuro-oncology practice. Identifying patients with a hereditary tumor predisposition permits appropriate tumor management as well as surveillance and risk-reduction measures for patients and their families. The American College of Medical Genetics and Genomics and the National Society of Genetic Counselors recently published referral guidelines for tumor predisposition assessment, providing an impetus to review the use of genetic counseling in neuro-oncology and to describe features of the less stereotypic conditions from the perspective of neuro-oncology practice. This review also provides a framework for the identification and management of these conditions, as well as references to guidelines and resources for providers and patients.
© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  brain tumor; familial; genetic; genetic counseling; hereditary

Year:  2015        PMID: 31579518      PMCID: PMC6760343          DOI: 10.1093/nop/npv051

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  27 in total

1.  Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS).

Authors:  Alanna F Bree; Maulik R Shah
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

2.  Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

Authors:  Saba Sharif; Rosalie Ferner; Jillian M Birch; James E Gillespie; H Rao Gattamaneni; Michael E Baser; D Gareth R Evans
Journal:  J Clin Oncol       Date:  2006-06-01       Impact factor: 44.544

3.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Authors:  Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N Armstrong; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Christoffer Johansen; Richard S Houlston; Sanjay Shete; Christopher I Amos; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel Lachance; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Rose Lai; Beatrice S Melin; Melissa L Bondy
Journal:  Eur J Cancer       Date:  2013-01-04       Impact factor: 9.162

4.  Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

Authors:  Jean-Sébastien Guillamo; Alain Créange; Chantal Kalifa; Jacques Grill; Diana Rodriguez; François Doz; Sébastien Barbarot; Michel Zerah; Marc Sanson; Sylvie Bastuji-Garin; Pierre Wolkenstein
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

5.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.

Authors:  L S Kirschner; F Sandrini; J Monbo; J P Lin; J A Carney; C A Stratakis
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 6.  PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.

Authors:  Joanne Ngeow; Charis Eng
Journal:  Methods       Date:  2014-10-22       Impact factor: 3.608

7.  Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.

Authors:  Thomas M Attard; Pierre Giglio; Sireesha Koppula; Carrie Snyder; Henry T Lynch
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

Review 8.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 9.  Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).

Authors:  Katharina Wimmer; Christian P Kratz; Hans F A Vasen; Olivier Caron; Chrystelle Colas; Natacha Entz-Werle; Anne-Marie Gerdes; Yael Goldberg; Denisa Ilencikova; Martine Muleris; Alex Duval; Noémie Lavoine; Clara Ruiz-Ponte; Irene Slavc; Brigit Burkhardt; Laurence Brugieres
Journal:  J Med Genet       Date:  2014-04-15       Impact factor: 6.318

10.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.

Authors:  Heather Hampel; Robin L Bennett; Adam Buchanan; Rachel Pearlman; Georgia L Wiesner
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

View more
  1 in total

1.  Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan.

Authors:  Kuo-Sheng Wu; Donald Ming-Tak Ho; Shiann-Tarng Jou; Alice L Yu; Huy Minh Tran; Muh-Lii Liang; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Shih-Chieh Lin; Feng-Chi Chang; Min-Lan Tsai; Yen-Lin Liu; Hsin-Lun Lee; Kevin Li-Chun Hsieh; Wen-Chang Huang; Shian-Ying Sung; Che-Chang Chang; Chun Austin Changou; Kung-Hao Liang; Tsung-Han Hsieh; Yun-Ru Liu; Meng-En Chao; Wan Chen; Shing-Shung Chu; Er-Chieh Cho; Tai-Tong Wong
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.